UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$ (17,029)	$ (19,707)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, Depletion and Amortization, Nonproduction	530	600
Share-based Payment Arrangement, Noncash Expense	1,789	3,789
Gain (Loss) on Investments	806	6,070
Foreign currency (gain) loss	(624)	(62)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	0	(1,040)
Operating Lease, Impairment Loss	0	2,461
Deconsolidation, Gain (Loss), Amount	0	(1,961)
Gain (Loss) on Extinguishment of Debt	0	(2,897)
Increase (Decrease) in Accounts Receivable	657	(353)
Increase (Decrease) in Prepaid Expense and Other Assets	1,078	1,442
Increase (Decrease) in Accounts Payable	(536)	(501)
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	(3,127)	743
Net cash used in operating activities	(16,363)	(11,416)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment	(211)	(280)
Cash Divested from Deconsolidation	0	(836)
Other	(595)	0
Net cash used in investing activities	(806)	(1,116)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock	0	534
Proceeds from Issuance or Sale of Equity	0	20,114
Payment, Tax Withholding, Share-based Payment Arrangement	(102)	(186)
Contingent Consideration Settlement, Cash	0	(2,500)
Net cash provided by (used in) financing activities	(102)	17,962
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(812)	(380)
Net increase (decrease) in cash, cash equivalents and restricted cash	(18,083)	5,050
Cash, cash equivalents and restricted cash, beginning of period	28,739	25,570
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total	$ 10,656	$ 30,620